Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters

Launched by ATLANTIC HEALTH SYSTEM · Jul 27, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a product called LiviWell, which is designed to absorb semen after sexual intercourse. Researchers want to see if using this product can help improve vaginal health by reducing issues such as odor and discharge, which some women experience after sex. The goal is to gather more information about how well the product works in a broader group of women.

To participate in this study, women need to be over 18 years old and sexually active with biological men. They should be willing to use the product and live in the continental United States. Participants must also be able to read, write, and understand English. However, women who are currently pregnant, trying to get pregnant, or have difficulties using the product due to physical limitations cannot take part. If eligible, participants can expect to provide feedback on their vaginal health while using the product, helping researchers understand its effectiveness. This study is not yet recruiting participants, so those interested will need to wait for further announcements.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Over 18 (for pH subset, 18-45)
• • Sexually-active with biological men
• • Willing and able to use product
• • Resides in continental USA
• • Understands, reads, writes, and speaks English
• Exclusion Criteria:
• • Currently Pregnant or are trying to conceive
• • Unable to use device due to poor motor function
• • Unable to sign informed consent